Dysbetalipoproteinemia

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Dysbetalipoproteinemia trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 3 trials

RecruitingPhase 2

NCT07392723

ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults

This randomized, double-blind, placebo-controlled pilot trial will evaluate the effects of alpha-linolenic acid (ALA) supplementation on cognitive function, blo…

United States20 participantsStarted 2025-01-12

Treatment: Alpha-Linolenic Acid (2.6 g/day), Placebo Control Group

RecruitingNot Applicable

NCT04815005

HoFH, the International Clinical Collaborators Registry

Homozygous familial hypercholesterolemia (HoFH), a rare inherited disorder caused by bi-allelic mutations in the LDL Receptor pathway, is characterized by extre…

United States, Netherlands, South Africa1,000 participantsStarted 2017-01-24

Treatment: Demographics, diagnosis type, genotype, lipid profile, treatment allocation, country of residence.

RecruitingNot Applicable

NCT06535542

Integrating Whole Genome Sequencing and Digital Twins Into the Management of Hypercholesterolemia in Emiratis

This pilot study investigates integrating whole genome sequencing and digital twin technology for managing hypercholesterolemia in Abu Dhabi clinics. It aims to…

United Arab Emirates40 participantsStarted 2024-07-29

Treatment: Whole Genome Sequencing

All recent trials (12 shown)

CompletedNot Applicable

NCT00001168

Evaluation of Lipoproteins

Lipoproteins are particles that carry fats such as cholesterol and triglycerides through the blood stream. These particles are involved in causing blood vessel…

United States1,017 participantsStarted 1979-01-01

Treatment: Balanced diet

CompletedNot Applicable

NCT05218005

Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia

ACCURATE will test the hypothesis that opportunistic genetic testing for Familial Hypercholesterolemia (FH) in patients admitted to hospital with an acute coron…

Canada140 participantsStarted 2022-01-01

Treatment: Research-based genetic test for Familial Hypercholesterolemia

Dysbetalipoproteinemia

Trial phase breakdown

Trial status

Actively recruiting — 3 trials

ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults

HoFH, the International Clinical Collaborators Registry

Integrating Whole Genome Sequencing and Digital Twins Into the Management of Hypercholesterolemia in Emiratis

All recent trials (12 shown)

Evaluation of Lipoproteins

Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia

Trial phase breakdown

Trial status

Actively recruiting — 3 trials

ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults

HoFH, the International Clinical Collaborators Registry

Integrating Whole Genome Sequencing and Digital Twins Into the Management of Hypercholesterolemia in Emiratis

All recent trials (12 shown)

Evaluation of Lipoproteins

Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia

Compassionate Use of Evinacumab

Genetic Testing and Motivational Counseling for FH

Effects of Evolocumab Versus Placebo Added to Standard Lipid-lowering Therapy on Fasting and Post Fat Load Lipids in Pat…

Perioperative Research Into Memory, Genomics in the Intensive Therapy Unit: Alzheimer's

DARK STUDY "DysbetalipoproteinemiA and atheRoma Risk"

Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.

Type III Dysbetalipoproteinemia